These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 21391458)

  • 1. Prior use of durable medical equipment as a risk adjuster for health-based capitation.
    van Kleef RC; van Vliet RC
    Inquiry; 2010-2011 Winter; 47(4):343-58. PubMed ID: 21391458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The high costs of death: should health plans get higher payments when members die?
    van Vliet RC; Lamers LM
    Med Care; 1998 Oct; 36(10):1451-60. PubMed ID: 9794339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiyear diagnostic information from prior hospitalization as a risk-adjuster for capitation payments.
    Lamers LM; van Vliet RC
    Med Care; 1996 Jun; 34(6):549-61. PubMed ID: 8656721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk-adjusted capitation based on the Diagnostic Cost Group Model: an empirical evaluation with health survey information.
    Lamers LM
    Health Serv Res; 1999 Feb; 33(6):1727-44. PubMed ID: 10029506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variations in the persistence of health expenditures and the implications for the design of capitation payments in Taiwan.
    Ku LJ; Chiou MJ; Liu LF
    J Health Serv Res Policy; 2015 Jul; 20(3):146-53. PubMed ID: 25829410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacy costs groups: a risk-adjuster for capitation payments based on the use of prescribed drugs.
    Lamers LM
    Med Care; 1999 Aug; 37(8):824-30. PubMed ID: 10448725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Pharmacy-based Cost Group model: validating and adjusting the classification of medications for chronic conditions to the Dutch situation.
    Lamers LM; van Vliet RC
    Health Policy; 2004 Apr; 68(1):113-21. PubMed ID: 15033558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modeling Medicare costs of PACE (Program of All-Inclusive Care for the Elderly) populations.
    Robinson J; Karon SL
    Health Care Financ Rev; 2000; 21(3):149-70. PubMed ID: 11481753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of diagnosis-based risk adjustment models to predict individual health care expenditure under the National Health Insurance system in Taiwan.
    Chang RE; Lai CL
    J Formos Med Assoc; 2005 Dec; 104(12):883-90. PubMed ID: 16607444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a risk-adjusted capitation model based on principal inpatient diagnoses in Taiwan.
    Lin W; Chang RE; Hsieh CJ; Yaung CL; Chiang TL
    J Formos Med Assoc; 2003 Sep; 102(9):637-43. PubMed ID: 14625609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CRGs: a new risk adjustment tool for capitation management.
    Capitation Manag Rep; 2001 Sep; 8(9):129-32. PubMed ID: 11577499
    [No Abstract]   [Full Text] [Related]  

  • 12. Improving risk adjustment for Medicare capitated reimbursement using nonlinear models.
    Veazie PJ; Manning WG; Kane RL
    Med Care; 2003 Jun; 41(6):741-52. PubMed ID: 12773840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk adjustment alternatives in paying for behavioral health care under Medicaid.
    Ettner SL; Frank RG; McGuire TG; Hermann RC
    Health Serv Res; 2001 Aug; 36(4):793-811. PubMed ID: 11508640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk-adjusted capitation payments: developing a diagnostic cost groups classification for the Dutch situation.
    Lamers LM
    Health Policy; 1998 Jul; 45(1):15-32. PubMed ID: 10183010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Free choice of health plan combined with risk-adjusted capitation payments: are switchers and new enrolees good risks?
    van Vliet RC
    Health Econ; 2006 Aug; 15(8):763-74. PubMed ID: 16498705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inferring capitation rates from aggregate health plans' costs.
    Shmueli A
    Health Econ; 1999 Sep; 8(6):547-52. PubMed ID: 10544320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Capitation and risk adjustment in health care financing: an international progress report.
    Rice N; Smith PC
    Milbank Q; 2001; 79(1):81-113; 2 p preceding VI. PubMed ID: 11286097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk-adjusted capitation: recent experiences in The Netherlands.
    van de Ven WP; van Vliet RC; van Barneveld EM; Lamers LM
    Health Aff (Millwood); 1994; 13(5):120-36. PubMed ID: 7868016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk adjusted premium subsidies and risk sharing: key elements of the competitive sickness fund market in the Netherlands.
    Lamers LM; van Vliet RC; van de Ven WP
    Health Policy; 2003 Jul; 65(1):49-62. PubMed ID: 12818745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk adjustment and the fear of markets: the case of Belgium.
    Schokkaert E; Van de Voorde C
    Health Care Manag Sci; 2000 Feb; 3(2):121-30. PubMed ID: 10780280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.